ArticleJAAD international2026

Originator versus biosimilar adalimumab in hidradenitis suppurativa: A multicenter real-world analysis of clinical response, maintenance of response, and switching.

Marra Aghajani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.